Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A 24 Week, Double-blind, Placebo-controlled, Multisite Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00726713
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:27.313569+00:00
Published At
2013-08-30T00:00:00+00:00
Record Updated At
2013-08-30
Results Posted At
2013-08-30
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Type 2 Diabetic Peripheral Neuropathy (DPN)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-08-30"
protocolSection.identificationModule.nctId
"NCT00726713"
protocolSection.identificationModule.officialTitle
"A 24 Week, Double-blind, Placebo-controlled, Multisite Study of Metanx\u00ae in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2013-08-30"

Study condition terms

  • Type 2 Diabetic Peripheral Neuropathy (DPN) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.